Microbe of nasal mucus

The term "Microbes in nasal mucus" denotes the diverse population of microorganisms—primarily bacteria, but also fungi and viruses—that inhabit the mucus lining of the human nasal mucosa. Major bacterial phyla include Firmicutes, Actinobacteria, Proteobacteria, Bacteroidetes, and Fusobacteria. Dominant genera commonly found are Staphylococcus, Corynebacterium, Alloiococcus, Moraxella, and Ralstonia. These microbial communities are critical in maintaining healthy mucosal barriers, shaping innate and adaptive immune responses (such as IgA production and T cell modulation), regulating epithelial function, and competing with invasive pathogens. Disruption of the normal microbial balance (dysbiosis) is implicated in the pathogenesis of allergic rhinitis, chronic rhinosinusitis, asthma, and may influence tissue remodeling and polyp formation. Notably, overgrowth of certain microbes (such as Staphylococcus aureus) in the context of dysbiosis is associated with biofilm formation, resistance to antibiotics, and exacerbated mucosal inflammation. Microbial composition can vary by anatomical site, patient health status, age, and environmental exposures. This entity is not a specific molecular target or canonical therapeutic target but rather a collective descriptor for a complex microbial ecosystem. No known drugs "target" the total microbial population of nasal mucus in the way that molecular drugs target receptors or enzymes, though interventions such as antibiotics, probiotics, or microbiome modulation therapies may incidentally alter this community. "Microbes in nasal mucus" refers to a diverse, non-canonical target made up of multiple microbial species, whose balance is crucial for nasal health but is not itself a molecular target or therapeutic receptor.

Other names

Nasal mucus microbiotaNasal mucosal microbiomeNasal floraNasal microbial communityNasal cavity commensalsNasal microbiota